InvestorsHub Logo
Followers 41
Posts 3508
Boards Moderated 2
Alias Born 09/20/2007

Re: None

Monday, 10/26/2020 10:58:16 PM

Monday, October 26, 2020 10:58:16 PM

Post# of 925
MORE REASONS I THINK QSAM HAS A BRIGHT FUTURE!

There are some pretty exciting things in the future of QSAM.

QSAM THERAPEUTICS! Also: QSAM PHARMACEUTICALS


Want a sample?? Check out their new website. I don't know that it has been PR'd yet, but I found it with a google search>

https://qsambio.com/

About QSAM
"QSAM Therapeutics, Inc. (“QSAM”), a wholly-owned subsidiary of QSAM Biosciences, Inc. (OTCQB: QSAM), is developing next generation nuclear medicines for the treatment of cancer and related diseases and conditions.

"QSAM’s initial technology is Samarium-153 DOTMP, aka CycloSam®, a clinical-staged bone targeting radiopharmaceutical from IsoTherapeutics Group, leaders in the nuclear medicine space who also developed FDA-approved and commercially available Quadramet® (Samarium-153 EDTMP), indicated for pain palliation.


"CycloSam® has already demonstrated safety and efficacy in animal studies and a human trial performed at the prestigious Cleveland Clinic. This drug candidate utilizes an FDA approved radioisotope combined with a novel chelate that has demonstrated increased efficacy and decreased side effects in animal models. Further, CycloSam® utilizes a streamlined, just-in-time manufacturing process. Given these factors, management believes there is a strong pathway to commercialization.

"CycloSam® is cleared by the FDA under an investigator IND to commence human dosing immediately in patients with osteosarcoma and bone metastasis. CycloSam® was also cleared by FDA and successfully used under a single-patient IND to perform bone marrow ablation prior to allogenic marrow transplantation (BMA/T) in 2020."

Watch for opportunities with those you trust.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent QSAM News